Prenatal DHA and Neurofunctional Development

The purpose of this study is to learn how much DHA to give to mothers in order to provide
enough to the baby. Researchers will also learn if there are differences in development of
the baby up to 12 months after birth.

Eligibility Criteria

Inclusion Criteria:

- Women in their 12th to 20th week of gestation

- Participants agree to consume the study capsules from enrollment to delivery

- Healthy weight, overweight and obese women (determined by body mass index; BMI) are
eligible

- Must be available by telephone

Exclusion Criteria:

- Underweight women and women who exceed 250 lbs at enrollment

- Women with serious systemic infection, cancer, major organ disease or systemic lupus
erythematosus

- Women with multiple infants or fetal diagnosis of congenital cardiac structural or
conduction defects or brain malformations

- Diagnosis of Type I diabetes, and/or hypertension

- Reported drug and/or alcohol abuse

- Unwilling to take capsules, or be contacted by phone

- Do not understand English

Principal Investigator

Kathleen Gustafson, PhD

Study Contact

Sarah Crawford 913-588-3781

Estimated Completion Date

Sunday, March 1, 2020

ClinicalTrials.gov #

NCT02709239
03/15/2016